Neurocrine Biosciences (NBIX) Price to Earnings (2011 - 2026)
Neurocrine Biosciences' (NBIX) Price to Earnings was 24.27 for Q2 2026, down 32.1% from 35.73 a year earlier but up 22.4% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Price to Earnings (2011 - 2026) Analysis & Trends
For FY2025, Price to Earnings at Neurocrine Biosciences was 29.66, down 25.4% from FY2024.
- Price to Earnings has declined for four consecutive years.
- By year, Price to Earnings came in at 39.75 in FY2024 (-23.7%), 52.08 in FY2023 (-30.2%), 74.60 in FY2022 (-17.3%) and 90.21 in FY2021 (+310.0%).
- Five-year quarterly Price to Earnings spans a low of 19.82 in Q1 2026 and a high of 763.86 in Q2 2022.
- Year over year, Price to Earnings has now declined in each of the last three quarters, with an average decline of 22.8% over the last eight quarters.
- The high point for year-over-year Price to Earnings in five years was Q3 2022 (growth of 757.9%); the low point was Q2 2023 (a decline of 93.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 19.82 (Q1 2026), 29.66 (Q4 2025) and 32.70 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.27 |
| Mar 31, 2026 | 19.82 |
| Dec 31, 2025 | 29.66 |
| Sep 30, 2025 | 32.70 |
| Jun 30, 2025 | 35.73 |
| Mar 31, 2025 | 35.81 |
| Dec 31, 2024 | 39.75 |
| Sep 30, 2024 | 30.22 |
| Jun 30, 2024 | 40.95 |
| Mar 31, 2024 | 37.53 |
| Dec 31, 2023 | 52.08 |
| Sep 30, 2023 | 57.84 |
| Jun 30, 2023 | 52.18 |
| Mar 31, 2023 | 154.20 |
| Dec 31, 2022 | 74.60 |
| Sep 30, 2022 | 175.37 |
| Jun 30, 2022 | 763.86 |
| Mar 31, 2022 | 125.39 |
| Dec 31, 2021 | 90.21 |
| Sep 30, 2021 | 20.44 |
API Access
Neurocrine Biosciences Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();